Amesite Introduces NurseMagic Enterprise Tier for Healthcare Providers: AI-Driven Solution for Seamless Integration with Existing Workflows and Scalable Pricing Model
AinvestTuesday, Jul 15, 2025 11:12 am ET

Amesite has launched NurseMagic Enterprise Tier, an AI-driven solution for mid- and large-scale post-acute healthcare providers. The platform integrates seamlessly into existing workflows and is priced based on patient census, offering a scalable solution that aligns with the interests of healthcare providers. This move positions Amesite for expanded market reach and sustained revenue growth.
Amesite Inc. (NASDAQ: AMST) has announced the launch of its NurseMagic™ Enterprise Tier, a cutting-edge AI-driven solution designed to meet the needs of mid- and large-scale post-acute healthcare providers. This new offering integrates seamlessly into existing workflows and is priced based on patient census, offering a scalable solution that aligns with the interests of healthcare providers. The move positions Amesite for expanded market reach and sustained revenue growth.NurseMagic™ Enterprise features several advanced capabilities, including seamless integration with electronic medical records (EMRs), automated interdisciplinary team (IDT) reporting, and custom-formatted documentation for compliance and billing. These features aim to enhance operational efficiency and compliance for healthcare providers.
One of the key innovations is the census-based pricing model, which ties pricing to patient census rather than staff count. This model allows organizations to scale revenue in alignment with their care delivery, eliminating friction that may limit full enterprise adoption. This pricing structure supports growth without operational disruption and positions Amesite to capture revenue as patient census expands.
The new tier is designed to support providers delivering care at scale, with features engineered to fit within current team structures. Seamless EMR integration ensures that documentation created in NurseMagic™ Enterprise can populate directly into clinical systems, while automated IDT reporting streamlines one of the most time-intensive compliance processes for home health and hospice agencies.
Amesite believes that this new offering significantly expands its addressable market and supports long-term revenue growth. The company will discontinue new sales of its entry-level B2B Teams plan, focusing instead on the NurseMagic™ Enterprise Tier and the Teams Plus+ premium tier. Existing Teams customers will continue to be supported.
The launch of NurseMagic™ Enterprise follows a series of recent enhancements, including the Teams Plus+ premium tier, multilingual capabilities, and expanded functionality supporting both clinical and non-clinical roles. NurseMagic™ is currently used across all 50 U.S. states and 21 countries, reflecting Amesite's ambition to capture significant market opportunities in the healthcare sector.
References:
1. [https://www.morningstar.com/news/globe-newswire/9493370/amesite-launches-census-based-enterprise-tier-for-nursemagic-to-drive-revenue-growth-and-meet-enterprise-demand-significantly-expanding-total-addressable-market](https://www.morningstar.com/news/globe-newswire/9493370/amesite-launches-census-based-enterprise-tier-for-nursemagic-to-drive-revenue-growth-and-meet-enterprise-demand-significantly-expanding-total-addressable-market)
2. [https://www.quiverquant.com/news/Amesite+Inc.+Launches+NurseMagic%E2%84%A2+Enterprise+Tier+to+Enhance+Healthcare+Documentation+for+Mid-+and+Large-Scale+Providers](https://www.quiverquant.com/news/Amesite+Inc.+Launches+NurseMagic%E2%84%A2+Enterprise+Tier+to+Enhance+Healthcare+Documentation+for+Mid-+and+Large-Scale+Providers)

Sign up for free to continue reading
Unlimited access to AInvest.com and the AInvest app
Follow and interact with analysts and investors
Receive subscriber-only content and newsletters
or
By continuing, I agree to the
Market Data Terms of Service and Privacy Statement
Already have an account?
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet